stars 1 stars 2 stars 3

EMBioSys has developed Efinia™, a revolutionary platform for the treatment of cancer with the potential to dramatically improve clinical outcomes as a new cancer treatment modality starting with breast cancer...then other solid tumors. Efinia™ delivers iEF Therapy (low intensity induced electric fields) to the treat the patient from the comfort of home, or while on the go. Our vision is to empower patients and providers with a new standard of cancer care.

EMBioSys Questions

Chris Barron is the Co-Founder and CEO of EMBioSys.

2 people are employed at EMBioSys.

Top EMBioSys Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users